Detalhe da pesquisa
1.
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance.
Br J Clin Pharmacol
; 89(5): 1601-1616, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454221
2.
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
Lancet Oncol
; 16(4): 447-56, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800891
3.
Non-Small Cell Lung Cancer, Version 6.2015.
J Natl Compr Canc Netw
; 13(5): 515-24, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25964637
4.
Non-small cell lung cancer, version 1.2015.
J Natl Compr Canc Netw
; 12(12): 1738-61, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25505215
5.
Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 11(5): 562-76, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23667206
6.
Non-small cell lung cancer, version 2.2013.
J Natl Compr Canc Netw
; 11(6): 645-53; quiz 653, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23744864
7.
Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study.
Clin Pharmacol Ther
; 114(6): 1375-1386, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777827
8.
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001909
9.
Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.
Cancer Immunol Immunother
; 61(1): 9-18, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21811785
10.
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.
Blood
; 116(2): 171-9, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20400682
11.
Novel therapies in phase II and III trials for malignant pleural mesothelioma.
J Natl Compr Canc Netw
; 10(1): 42-7, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22223868
12.
Non-small cell lung cancer.
J Natl Compr Canc Netw
; 10(10): 1236-71, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054877
13.
The evolution of multimodality therapy for malignant pleural mesothelioma.
Curr Treat Options Oncol
; 12(2): 163-72, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21404104
14.
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.
Cancer Immunol Immunother
; 59(10): 1467-79, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20532500
15.
Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.
Clin Lung Cancer
; 21(6): 527-533, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32859536
16.
Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy.
Clin Lung Cancer
; 20(4): 287-296.e4, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130450
17.
A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.
Clin Cancer Res
; 13(9): 2692-8, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17473201
18.
The value of gamma camera and computed tomography data set coregistration to assess Lewis Y antigen targeting in small cell lung cancer by (111)Indium-labeled humanized monoclonal antibody 3S193.
Eur J Radiol
; 67(2): 292-299, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17714905
19.
Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
Cancer Res
; 66(6): 2970-9, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16540645
20.
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
J Clin Oncol
; 36(23): 2386-2394, 2018 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29906251